Skip to content Skip to footer
Top Performing Drug of 2021 – Xarelto (November Edition)

Top Performing Drug of 2021 – Xarelto (November Edition)

Active Ingredient: rivaroxaban  Strength: 2.5 mg, 10 mg, 15 mg, and 20 mg  Dosage Form: Tablets  Mechanism of Action: Factor Xa inhibitors  First Approval: US (1 Jul 2011), EU (30 Sep 2008)  Revenue Analysis of Xarelto1  Xarelto has been an important driver of the revenue generated from the cardiovascular portfolio of Janssen. The blood thinner showed an increase of 4%…

Read more